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Introduction
Deemed “the inexcusable disease” by Edsall in 1876,’ tetanus
remains a potentially fatal disease that is easily preventable. Al
though vaccination is stressed, and its benefit is well-known, many
cases are reported each year in the United States, especially in those
shown to be at increased risk.2 Tetanus must be recognized in its
early stages, and it should be considered in patients with uncertain
immunization status. Herein, we describe the case of a patient from
the Marshall Islands who received treatment in our medical facility.
Case Report
A 22-year-old Marshallese male presented with complaint of
fever and lower back pain. He was admitted to the hospital in Majuro
where he was found to have a temperature of 102 degrees Fahrenheit
and significant muscular rigidity. He was treated with diazepam five
milligrams intravenously and ibuprofen 800 milligrams orally as
needed for symptoms. He was given penicillin G, ceftriaxone, and
gentamicin as well as tetanus toxoid.
There was no known past medical history, and immunizations
were reportedly up-to-date. The patient had undergone no surgeries.
His only medication prior to admission included an occasional
acetaminophen; he had no known drug allergies. He smoked ap
proximately three cigarettes per day, indulged in marijuana on the
weekends, and consumed alcohol infrequently. He was unem
ployed, but his daily activities included carrying heavy sacks. He
lived with his father and three others; he had no siblings.
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The patient was transferred to our medical facility five days after
his initial presentation. There had been no significant change in the
patient’s condition over this time period. On arrival history was
obtained with the assistance of an interpreter; there was no history
of trauma, bite, or penetrating wound. He denied headache, photo
phobia, or other symptoms. The medical attendant reported that
most adults in Majuro receive only the initial tetanus immunization
as children and rarely receive booster shots.
On physical examination, the patient was afebrile (temperature,
98.4 degrees Fahrenheit) and tachycardic (pulse, 117 beats per
minute); his blood pressure was 130/59 and respirations were 27
breaths per minute. In general, he was alert and oriented; there was
noticeable discomfort with movement. Pupils were equal and reac
tive, extraocular movements were intact. There was decreased jaw
mobility with a two-centimeter opening. Nuchal rigidity was also
evident. Lungs were clear to auscultation. Heart sounds were regu
lar. The abdomen was intermittently rigid with audible bowel
sounds. Superficial cutaneous abrasions were noted on the right
elbow and bilateral pretibial regions; otherwise, no obvious punc
ture wounds or entry sites were identified. Neurologic examination
was notable for restricted conjugate gaze, risus sardonicus with mild
stimulation, and increased spastic tone throughout; there was no
clonus. Laboratory data including complete blood count, electro
lytes, and urinalysis which were within normal limits; hepatic panel
was notable for an aspartate aminotransferase of 202 UIL. Creatine
kinase was 5520 UIL.
The patient was admitted to the intensive care unit where obser
vation was required due to the need for sedation and subsequent risk
of respiratory compromise and cardiac arrest. He was given human
tetanus immune globulin (HTIG) 500 unit dose to neutralize the
tetanus toxin. His antibiotic regimen was altered to include metron
idazole 500 mg intravenously every six hours given its decreased
GABA agonist activity compared to penicillin G. Supportive mea
sures were initiated including diazepam 10 milligrams intrave
nously every six hours for sedation, seizure prophylaxis, and control
of muscle spasms. Propanolol 20 milligrams orally every six hours
was given to decrease sympathetic tone. An intravenous fentanyl
drip at 100 micrograms per hour was initiated to control pain.
Sedation was later achieved with a lorazepam drip at one milligram
per hour. Decubitus and aspiration precautions were observed; deep
venous thrombosis prophylaxis was with heparmn 5,000 units subcu
taneously twice daily. Unnecessary stimuli were avoided.
Treatment was largely supportive throughout the remainder ofour
patient’s one month hospitalization. Attention was focused on
preventive measures to include control of spasms, autonomic hyper
activity, pain, stimuli, and malnutrition. Opisthotonic posturing was
noted with verbal and tactile stimuli and occasionally while the
patient slept. Nutrition remained marginal for the first two weeks of
the hospitalization despite efforts to provide supplementation, and
a percutaneous endoscopic gastrostomy tube was placed by gastro
enterology on hospital day number nineteen. The patient’s rigidity
gradually subsided and sedation was tapered. He recovered com
pletely and was without neurological sequelae. There were no
respiratory complications. The patient was discharged on hospital
day number thirty with a plan for rehabilitation of deconditioning.
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Discussion
The incidence of tetanus in the United States has declined signifi
cantly since 560 cases were reported in the year 1947. The reported
average of 41 cases annually for the years 1995-1997 was the lowest
to date with 0.15 cases per million population.2 Immunization
remains the key to prevention; few patients with tetanus (13%) have
received a primary series of tetanus vaccination and only 33%
receive proper wound prophylaxis.2 Several factors have been
associated with decreased immunity, and despite emphasis on the
need for immunization, the risk remains highest in minorities, the
elderly (especially women), the poverty-stricken, the uneducated,
and those born outside the United States.4 This trend has gone
unchanged for decades and accounts for higher mortality rates our
elderly population.2’45In underdeveloped countries the figures re
main staggering with 50,000 deaths due to tetanus each year.5
Trismus is reported in almost all patients with tetanus.5’6The
initial presentation is often accompanied by dysphagia, headache,
restlessness, and nuchal rigidity.6’7In the generalized form of teta
nus, the condition progresses to spasms with a “sudden burst of tonic
contractions of muscle groups causing opisthotonus, flexion, and
adduction of the arms with clenching of the fists on the thorax”.7
Extension of the legs completes this picture of what as been
described as the “tetanic seizure”.7’8Spasms occur with minimal
stimuli and can be quite painful.9All muscle groups can be affected
leading to respiratory paralysis, a well-known complication of the
disease.8’9Autonomic dysfunction has emerged as the leading cause
of death in these patients and is characterized by tachycardia,
arrhythmias, excess sweating, and labile hypertension.6”°
The diagnosis of tetanus remains one of clinical suspicion. Labo
ratory data is often either unreliable or unavailable.5’8Muscular
rigidity coupled with sympathetic overactivity distinguishes tetanus
from other ailments which it may mimic such as tetany, meningitis,
stiff-man syndrome, rabies, hysteria, strychnine poisoning, and
dystonic reactions.9’1 Patients with a history of injury followed by
symptoms and those without clear portal of entry should be consid
ered at risk for tetanus and treated.7”
Treatment focuses on efforts to neutralize the toxin, debride the
wound, and provide supportive care.5 HTIG neutralizes the toxin
and shortens the course of the disease.’8Surgical debridement and
removal of foreign matter may be required in some cases. Admin
istration of metronidazole has been shown to improve survival, and
special attention should be given to airway protection, inhibition of
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seizures, and treatment of autonomic dysfunction.5 Benzodiaz
epines are recommended to control spasms, provide sedation, and
prevent tetanic seizures; neuromuscular blockade may be consid
ered in severe cases.8 Control of autonomic dysfunction can be
achieved with beta blockers or morphine; however, beta blockers
have been associated with an increased risk of cardiac arrest and
should be administered in a monitored setting.5’8
Prevention has gone unchanged for decades and consists of
vaccination and wound care.’2 Primary immunization in patients
younger than 7 years of age includes injection with diphtheria,
tetanus, and pertussis (DTP) vaccine at ages 2, 4, 6 and 15 months
with boosters at 4 to 6 years and at 11 to 12 years of age.25”3Three
injections with tetanus and diphteria (Td) four weeks apart followed
by booster at one year is reserved for those requiring primary
immunization at an age greater than seven.5”All patients should
receive Td booster every ten years. Wound prophylaxis is based on
the patient’s immunization status and classification of the wound as
tetanus-prone (greater than six hours old, contaminated, deep and
infected) or nontetanus-prone (less than six hours old, clean, super
ficial, and noninfected).2’58Tetanus-prone wounds in patients with
uncertain immunization status require primary immunization and
HTIG.2”°If immunization can be proven or the wound is clean, no
HTIG is required.2If it has been more than ten years since the last
booster in a nontetanus-prone wound or more than five years in a
tetanus-prone wound, a booster shot should be given, even in those
with up-to-date immunization.2
This case illustrates the classic presentation of tetanus. No portal
of entry is identified in many patients, and uncertain immunization
status cannot be relied upon. Our patient responded well to support
ive therapy and had an uncomplicated course. The importance of
vaccination cannot be overemphasized. Unfortunately, our knowl
edge of the fatal nature of tetanus and the methods by which it can
be prevented has not aided us in eliminating the disease. Primary
care providers must routinely screen their patients for vaccination
status, as the prevalence remains high in our elderly and others at
increased risk. Indeed, there is no excuse.
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